More
    Guided Solutions - Connecting Talent With Innovation/div>

    Brainreader secures €6.6m for brain diagnostic commercialisation

    Danish MedTech Brainreader has secured €6.6m ($7.3m) to support the market rollout of Neuroreader, its AI-based brain diagnostic software platform. The funding round was led...

    Surgify Medical secures $7.97M to advance bone surgery technology

    Finnish company Surgify Medical has secured €7m ($7.97m) in Series A funding to expand the reach of its Surgify Halo technology, which aims to...

    EBR Systems raises $36.1M for leadless pacing tech

    EBR Systems received commitments for a fully underwritten institutional placement to raise $36.1 million (A$55.9 million). In addition to the committed funding, the company...

    Salvia BioElectronics secures $60M in oversubscribed Series B round

    Salvia BioElectronics, a clinical-stage medical device company pioneering neuromodulation therapy for people with chronic migraine, announced the successful completion of a $60 million (€53...

    Pulnovo Medical welcomes EQT as a new investor, following CE-MDR approval

    Globally recognised pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF) Pulnovo Medical has received new investment from EQT Group, a...

    Alpheus Medical raises $52m for ultrasound-activated tumour therapy

    Alpheus Medical announced it closed an oversubscribed Series B financing round, bringing in $52 million. The Chanhassen, Minnesota–based solid body cancer treatment developer plans to...

    Insight Surgery completes $2.5m Series A funding round

    This investment follows the granting of FDA 510(k) clearance for the company’s surgical guides for orthopedic and orthopedic-oncology surgery and will be used to...

    Mentaily raises $3M for genAI mental health diagnostic

    Israeli startup Mentaily has raised $3m in seed financing to advance the development of LIV, a mental health diagnosis and support tool. Underpinned by generative...

    ClearPoint Neuro announces investment of up to $110M by Oberland Capital

    ClearPoint Neuro, a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it has entered...

    Latest articles